ICD trials: An extraordinary means of determining patient risk?

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 7, 1998, Pages 1341-1346

  Nisam, Seah ^a,c   Mower, Morton ^b  

^a CPI/Guidant   (Belgium)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Guidant European Headquarters   (Belgium)

Author keywords

Implantable defibrillator; Prospective studies; Risk stratification

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; SOTALOL;

CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; EDITORIAL; HEART ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

DEFIBRILLATORS, IMPLANTABLE; EVALUATION STUDIES; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0031878213     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00203.x     Document Type: Editorial

References (19)

1. Mirowski M, Reid P, Mower M, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322-324.
2. Moss A, Hall J, Cannom D, et al. for the MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias. N Engl J Med 1996; 335:1933-1940.
3. The Antiarrhythmic Versus Implantable Defibrillator (AVlD) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
4. Wever E, Hauer R, Van Capelle F, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995; 91:2195-2203.
5. Kuck K-H, Cappato, R. Implantable heart defibrillator saves lives in patients with previous cardiac arrest. Oral presentation during "Hotline session: New-breaking clinical trials," at 47th annual scientific sessions of the American College of Cardiology meeting, Atlanta, GA. (Press Release, 30 March 1998).
6. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997; 337:1569-1575.
7. Connolly S. Results from the Canadian Implantable Defibrillator Study (CIDS). Oral presentation during "Hotline session: New-breaking clinical trials," at 47th annual scientific sessions of the American College of Cardiology meeting, Atlanta, GA (Press Release, 30 March 1998).
8. Nisam S, Breithardt G. Mortality trials with implantable defibrillators. Am J Cardiol 1996; 79:468-471.
9. Fogoros R, Elson J, Bonnet C, et al. Efficacy of the automatic implantable cardioverter defibrillator in prolong survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990; 16:381-386.
10. Narasimhan C, Dhala A, Axtell K, et al. Comparison of outcome of implantable cardioverter defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease. Am J Cardiol 1997; 80:1305-1308.
11. Jeevanandam V, Bielefeld M, Auteri J, et al. The implantable defibrillator: An electronic bridge to cardiac Transplantation. Circulation 1992; 86:(II)276-279.
12. Grimm M, Grimm G, Zuckermann A, et al. ICD therapy in survivors of sudden cardiac death awaiting heart transplantation. Ann Thora Surg 1995; 59:916-920.
13. Bigger JT. Primary prevention of sudden cardiac death using implantable cardioverter-defibrillators. In I Singer (ed.): Implantable Cardioverter-Defibrillator. Armonk, New York, Futura Publishing Company, 1994, pp. 515-546.
14. Nisam S, Singer I. Prophylactic trials with implantable defibrillators: MADIT and beyond. Interv Cardiol 1998; (In Press.)
15. Myerburg R, Kessler K, Castellanos A. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119:1187-1197.
16. Wilber D, Kall J, Kopp D. What can we expect from prophylactic implantable defibrillators. Am J Cardiol 1997; 80(5B):20-27.
17. Nisam S, Thomas A, Mower M, et al. Identifying patients for prophylactic automatic implantable cardioverter defibrillator therapy: Status of prospective studies. Am Heart J 1991; 122:607-612.
18. Mower M, Thomas A, Nisam S, et al. Effectiveness of implantable cardioverter-defibrillators: Problems and progress in the design of randomized trials. J Electrocardiol 1994; 26:42-50.
19. Klein H, Trappe HJ, Fieguth HG, et al. Prospective studies evaluating prophylactic ICD therapy for high risk patients with coronary artery disease. PACE 1993; 16:564-570.